Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma
Objective: To investigate the safety, efficacy, and prognostic factors of hepatic arterial infusion chemotherapy (HAIC) with raltitrexed and oxaliplatin post-transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC). Methods: Thirty-seven patients with uHCC who received...
Main Authors: | Baojiang Liu, Xu Zhu, Song Gao, Jianhai Guo, Xiaodong Wang, Guang Cao, Linzhong Zhu, Peng Liu, Haifeng Xu, Hui Chen, Xin Zhang, Shaoxing Liu, Fuxin Kou |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-05-01
|
Series: | Journal of Interventional Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2096360219300882 |
Similar Items
-
Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
by: Shao W, et al.
Published: (2019-11-01) -
Survival Comparisons of Hepatic Arterial Infusion Chemotherapy With mFOLFOX and Transarterial Chemoembolization in Patients With Unresectable Intrahepatic Cholangiocarcinoma
by: Zhiyuan Cai, et al.
Published: (2021-04-01) -
Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020-01-01) -
The effect of transarterial chemoembolization therapy to survival in unresectable liver tumors
by: Mehmet Güli Çetinçakmak, et al.
Published: (2011-06-01) -
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study
by: Min-Ke He, et al.
Published: (2017-10-01)